Clinical Trials Directory

Trials / Unknown

UnknownNCT04962360

The Effect of Nutritional Formula Supplementation on Linear Growth of Growth Hormone (GH) Treated Prepubertal Children With Idiopathic Short Stature (ISS) After 2 Years From the Beginning of GH-therapy

The Effect of Nutritional Formula Supplementation on Linear Growth of GH Treated Prepubertal Children With Idiopathic Short Stature (ISS) After 2 Years From the Beginning of GH-therapy: a Randomized, Double- Blind, Placebo-controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
64 (estimated)
Sponsor
Rabin Medical Center · Academic / Other
Sex
All
Age
5 Years – 10 Years
Healthy volunteers
Not accepted

Summary

The proposed study is a double blind, randomized, placebo controlled study. The aim of the study is to evaluate the effect of combined growth hormone (GH) treatment \&nutritional formula supplementation versus GH \& placebo on growth parameters in 64 children with Idiopathic Short Stature (ISS) after the second year of GH treatment. Participants will be randomly assigned either to the intervention group or the placebo control group. Randomization for the two study groups will be made in a ratio of 1:1. Both participants and study team will be blinded to the type of treatment that each patient will receive during the study. The randomization will be done according to gender. Participants in the intervention groups will be treated with the study formula and participants in the control group will be treated with a placebo low caloric formula (powder added to water). The study will continue for 6 months of intervention versus active placebo, with additional 6 months (an extension period), in which participants at both groups, the intervention and the placebo, will be offered to continue their participation in the study with the active study supplement.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTNutritional supplementation standardized formulaPowder added to water, containing about 25% of recommended Daily Recommended Intake (DRI) for calories, high protein (25% of calories) and multivitamin and mineral (25%-100% of DRI for recommended daily allowance (RDA) or adequate intake
DIETARY_SUPPLEMENTPlaceboLow caloric formula (Powder added to water) without added vitamins and minerals

Timeline

Start date
2021-08-01
Primary completion
2025-07-01
Completion
2025-10-01
First posted
2021-07-15
Last updated
2024-03-26

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT04962360. Inclusion in this directory is not an endorsement.